Infectious disease companies develop technologies, diagnostics and therapeutics that prevent, detect and treat bacterial, viral, fungal and parasitic infections. Their work supports global health, outbreak response and disease surveillance.
This category includes companies working on:
Browse 118 UK infectious disease companies below.
Preclinical vaccines targeting antimicrobial-resistant bacterial infections
VacTimmune is a biotechnology company developing preventative vaccines against bacterial pathogens associated with antimicrobial resistance. Its preclinical pipeline includes candidates targeting Pseudomonas aeruginosa, Klebsiella pneumoniae and other clinically important bacteria, with an emphasis on infections…
T-cell immune profiling diagnostics and immunology research reagents
Virax Biolabs develops diagnostic tests that measure T-cell immune responses to viral infections. Its lead assay focuses on post-acute infection syndromes, including long COVID, and is intended to help characterise patients' cellular immune responses. The company also supplies immunology research reagents, including…
Rapid genomic diagnostic device for sepsis and bacterial infections
GenomeKey is a biotechnology company developing an in vitro diagnostic device that uses whole genome sequencing and machine learning to identify bacteria and their antimicrobial resistance profiles directly from patient blood within hours. The device targets sepsis, where current culture-based diagnostics take 24 to…
Anti-virulence drug discovery from natural bioactive compounds
Neem Biotech is a Wales-based drug discovery company developing novel non-traditional antimicrobial treatments derived from naturally inspired compounds. The company specialises in quorum sensing inhibitors and anti-biofilm agents, with programmes targeting wound infection and cystic fibrosis. Its discovery approach…
Point-of-care molecular diagnostic platform for rapid infectious disease detection
Diagnostics for the Real World (Europe) is a Cambridge University spin-out developing and commercialising a fully automated point-of-care molecular diagnostic system for rapid detection of infectious diseases. Using isothermal nucleic acid amplification, the platform delivers sample-in-result-out testing without…
Rapid point-of-care molecular diagnostics for infectious disease
Llusern Scientific is a diagnostics company developing portable, rapid molecular diagnostic systems for use at the point of care. Using isothermal amplification technology, the company's platform identifies bacterial pathogens directly from patient samples without laboratory infrastructure, delivering results within…
Contract research for animal health, aquaculture and biopharmaceutical biosafety
Moredun Scientific is a contract research organisation providing efficacy and safety testing services for veterinary and aquaculture products, and biosafety testing of biopharmaceuticals. The company conducts studies across major livestock species and fish using validated infectious disease models for bacteria,…
Specialist vaccine development and GMP manufacturing in Scotland
Valneva Scotland Limited is the UK manufacturing and R&D subsidiary of Valneva SE, a specialty vaccine company. Operating from an MHRA-authorised GMP facility in Livingston, the site produces commercial and pipeline vaccines including IXCHIQ, the world's first approved chikungunya vaccine, and IXIARO for Japanese…
Specialist respiratory CRO delivering human challenge trials and preclinical models
Virtus Respiratory Research is a contract research organisation specialising in early-stage clinical and preclinical research for respiratory drug development. The company conducts human virus challenge trials and in vitro preclinical studies focused on asthma, COPD, respiratory virus infections, and related…
Clinical-stage anti-infectives targeting antimicrobial resistance and infectious disease
NovaBiotics is a clinical-stage biotechnology company developing first-in-class anti-infective therapies for difficult-to-treat infectious diseases, with a focus on antimicrobial resistance. Its pipeline is built on two proprietary platforms: an anti-infective peptide platform yielding antifungal and antibacterial…
Point-of-care pharmacogenetic testing platform for emergency healthcare
Genedrive is a molecular diagnostics company developing point-of-need pharmacogenetic tests that identify genetic variants to guide safer, more personalised medicine decisions in time-critical emergency care. Its flagship products, developed and validated with NHS partners, include a neonatal test preventing…
Multiplex PCR and NGS diagnostics for cancer and infection
GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing. Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library…
Protein superglue vaccine platform targeting infectious disease and cancer
SpyBiotech is a clinical-stage biotechnology company developing vaccines using its proprietary protein superglue technology, which enables efficient and stable attachment of antigens to virus-like particle and viral vector delivery platforms. The approach improves immunogenicity and reduces manufacturing complexity…
Global influenza vaccine leader with major UK manufacturing in Liverpool
CSL Seqirus is one of the world's largest influenza vaccine companies, operating the only injectable influenza vaccine manufacturing facility in the UK at Speke, Liverpool. The site employs more than 650 people and produces egg-based and cell culture-derived influenza vaccines for seasonal and pandemic use, with surge…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free soluble nanoarray technology enables simultaneous quantification of up to 200 RNA and DNA targets from low-input samples within one hour.…
Polymer-based rapid diagnostic technology for bacterial and fungal infections
Molecular Titans is a University of Bradford spin-out developing a patented polymer nanotechnology platform for rapid infection diagnosis. Its thermoresponsive polymers bind selectively to bacterial and fungal pathogens, producing a measurable signal within minutes rather than days. Initial applications include…
Rapid point-of-care molecular testing for sexually transmitted infections
Binx Health is a diagnostics company that develops and manufactures a rapid point-of-care molecular testing platform for sexually transmitted infections. Its benchtop instrument and single-use cartridges detect the genetic material of chlamydia and gonorrhoea from patient samples in around 30 minutes, allowing…
Rapid microfluidic antimicrobial susceptibility testing for clinical laboratories
iFAST Diagnostics is a biotechnology company developing microfluidic instruments for rapid antimicrobial susceptibility testing of bacterial infections. Its platform uses electrical measurements of individual bacteria following antibiotic exposure to determine susceptibility and minimum inhibitory concentrations in…